10.1186/s40168-021-01126-6 Summary Keywords butyrate, diabetes, GLP-1, gut microbiota, leonurine, MPC2 Citation Zhang Y, Chen W, Yu X, Feng J, Sammad A, Wang Z and Yin K (2026) Leonurine ameliorates experimental type 2 diabetes through gut microbiota remodeling, enhanced butyrate production, and MPC2 activation to restore GLP-1 secretion

use clinical discretion Storage and Stability Store at 28C in refrigerator Do not freeze Use within 28 days of first puncture Maintain sterility and aseptic technique throughout use Ideal Candidates This compound is suitable for: Weight loss patients in medically supervised programs Athletes and bodybuilders in cutting or endurance phases Fatigue and mitochondrial dysfunction cases Individuals undergoing IV nutrient therapy or performance protocols Patients with metabolic, cardiac, or insulin-related dysfunctions L-Carnitine 100 mg/mL 30 mL Preservative-Free Injectable provides a clinically versatile, evidence-supported option for improving energy production , fat metabolism , and performance capacity
doi:10.1016/j.freeradbiomed.2016.02.028
March 2024 - The first status conference on the GLP-1 product liability litigation was held in Pennsylvania